Olivia Pagani

20.2k total citations
159 papers, 5.5k citations indexed

About

Olivia Pagani is a scholar working on Oncology, Cancer Research and Genetics. According to data from OpenAlex, Olivia Pagani has authored 159 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 106 papers in Oncology, 60 papers in Cancer Research and 59 papers in Genetics. Recurrent topics in Olivia Pagani's work include Breast Cancer Treatment Studies (56 papers), Estrogen and related hormone effects (35 papers) and Cancer Treatment and Pharmacology (32 papers). Olivia Pagani is often cited by papers focused on Breast Cancer Treatment Studies (56 papers), Estrogen and related hormone effects (35 papers) and Cancer Treatment and Pharmacology (32 papers). Olivia Pagani collaborates with scholars based in Switzerland, Italy and United States. Olivia Pagani's co-authors include Aron Goldhirsch, Fátima Cardoso, Richard D. Gelber, Alan S. Coates, Cristiana Sessa, Elżbieta Senkus, Beat Thürlimann, Karen N. Price, Ann H. Partridge and Marco Colleoni and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Olivia Pagani

152 papers receiving 5.4k citations

Peers

Countries citing papers authored by Olivia Pagani

Since Specialization

Citations

This map shows the geographic impact of Olivia Pagani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olivia Pagani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olivia Pagani more than expected).

Fields of papers citing papers by Olivia Pagani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olivia Pagani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olivia Pagani. The network helps show where Olivia Pagani may publish in the future.

Co-authorship network of co-authors of Olivia Pagani

This figure shows the co-authorship network connecting the top 25 collaborators of Olivia Pagani. A scholar is included among the top collaborators of Olivia Pagani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olivia Pagani. Olivia Pagani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Optimizing Premenopausal Hormone Receptor-Positive Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer Management in India: Insights From Expert Consensus 2024 ·Cureus ·Ashok K. Vaid, Olivia Pagani, (unknown), (unknown), Chirag Desai, Ghanashyam Biswas, Jyoti Wadhwa, (unknown), Seema Gulia, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	1
2	Management and Outcome of Young Women (≤40 Years) with Breast Cancer in Switzerland 2022 ·Cancers ·Giacomo Montagna, Robin Schaffar, Andrea Bordoni, Alessandra Spitale, Daniela Terribile, Lorenzo Rossi, (unknown), B. Lindén, Isabelle Konzelmann, Sabine Rohrmann, Katharina Staehelin, M. Maspoli-Conconi, Jean‐Luc Bulliard, Francesco Meani, Olivia Pagani, Elisabetta Rapiti	3
3	Current challenges and unmet needs in treating patients with human epidermal growth factor receptor 2-positive advanced breast cancer 2022 ·The Breast ·Matti Aapro, Fátima Cardoso, Giuseppe Curigliano, Alexandru Eniu, Joseph Gligorov, Nadia Harbeck, Andreas Mueller, Olivia Pagani, Shani Paluch–Shimon, Elżbieta Senkus, Beat Thürlimann, Khalil Zaman	7
4	A Breast Cancer Smartphone App to Navigate the Breast Cancer Journey: Mixed Methods Study 2021 ·JMIR Formative Research ·Serena Petrocchi, Chiara Filipponi, Giacomo Montagna, (unknown), Olivia Pagani, Francesco Meani	14
5	35P Prognostic impact of cytotoxic CD4 T cells (CD4 CTL) in tumour immune microenvironment of breast cancer patients 2021 ·Annals of Oncology ·Kyrillus S. Shohdy, (unknown), (unknown), Loay Kassem, Olivia Pagani	0
6	Long-term responders to trastuzumab monotherapy in first-line HER-2+ advanced breast cancer: characteristics and survival data 2019 ·BMC Cancer ·Sabine Schmid, Dirk Klingbiel, Stefan Aebi, Aron Goldhirsch, Christoph Mamot, Elisabetta Munzone, Franco Nolè, C. Oehlschlegel, Olivia Pagani, Bernhard C. Pestalozzi, Christoph Rochlitz, Beat Thürlimann, Roger von Moos, Patrik Weder, Khalil Zaman, Thomas Ruhstaller	7
7	The impact of depression on adherence to organized and opportunistic breast cancer screening 2019 ·European Journal of Cancer Prevention ·Giacomo Montagna, Andres R. Schneeberger, Lorenzo Rossi, (unknown), Fabienne D. Schwab, Andreas Schoetzau, Monika Eichholzer, Olivia Pagani, William P. Weber, Christian Kurzeder, Uwe Güth, Christian G. Huber	4
8	Incidence of hypocalcemia in a non-inferiority phase III trial assessing prevention of symptomatic skeletal events (SSE) with denosumab (DN) administered every 4 weeks (q4w) versus every 12 weeks (q12w): SAKK 96/12 (REDUSE) 2018 ·Annals of Oncology ·Roger von Moos, Hanne Hawle, Stefanie Hayoz, Richard Cathomas, Andreas Müller, Sabine Schmid, Olivia Pagani, (unknown), Daniel Rauch, Sandro Anchisi, Thomas Hermanns, Mathias K. Fehr, (unknown), (unknown), Martin Zweifel, (unknown), (unknown), (unknown), Silke Gillessen, Arnoud J. Templeton	4
9	Oncology Physicians' Perspectives on Practices and Barriers to Fertility Preservation and the Feasibility of a Prospective Study of Pregnancy After Breast Cancer 2017 ·Journal of Adolescent and Young Adult Oncology ·Shoshana M. Rosenberg, Shari Gelber, Richard D. Gelber, (unknown), Larissa A. Korde, Olivia Pagani, Ann H. Partridge	25
10	Unusual case of splenic sarcoidosis without morphological lesions detected by PET-CT in a patient with breast cancer: functional imaging between pitfalls and therapeutic guide 2017 ·ecancermedicalscience ·Gaetano Paone, Simona Di Lascio, Andrea Azzola, Luca Mazzucchelli, Olivia Pagani	0
11	Supportive care during treatment for breast cancer: Resource allocations in low- and middle-income countries. A Breast Health Global Initiative 2013 consensus statement 2013 ·The Breast ·Fátima Cardoso, Nuran Beşe, Sandra R. Distelhorst, José Luiz Barbosa Bevilacqua, Ophira Ginsburg, Steven M. Grunberg, Richard J. Gralla, (unknown), Olivia Pagani, Ann H. Partridge, Felícia Marie Knaul, Matti Aapro, Barbara L. Andersen, Beti Thompson, Julie R. Gralow, Benjamin O. Anderson	53
12	Differential expression of testin and survivin in breast cancer subtypes 2013 ·Oncology Reports ·Manuela Sarti, Sandra Pinton, Costanzo Limoni, Giuseppina M. Carbone, Olivia Pagani, Franco Cavalli, Carlo V. Catapano	13
13	Combination of trastuzumab and letrozole after resistance to sequential trastuzumab and aromatase inhibitor monotherapies in patients with estrogen receptor-positive, HER-2-positive advanced breast cancer: a proof-of-concept trial (SAKK 23/03) 2011 ·Endocrine Related Cancer ·Dieter Koeberle, Thomas Ruhstaller, Jost Langhorst, Olivia Pagani, Khalil Zaman, Roger von Moos, C. Oehlschlegel, S. Crowe, (unknown), Beat Thuerlimann	13
14	International Guidelines for Management of Metastatic Breast Cancer: Can Metastatic Breast Cancer Be Cured? 2010 ·JNCI Journal of the National Cancer Institute ·Olivia Pagani, Elżbieta Senkus, WC Wood, Marco Colleoni, Tanja Čufer, S. Kyriakides, (unknown), Eric P. Winer, Fátima Cardoso, (unknown)	292
15	CA15-3 and alkaline phosphatase as predictors for breast cancer recurrence: a combined analysis of seven International Breast Cancer Study Group trials 2007 ·Annals of Oncology ·Aparna Keshaviah, Silvia Dellapasqua, Nicole Rotmensz, J. Lindtner, Diana Crivellari, J. Collins, Marco Colleoni, Beat Thürlimann, C. Mendiola, Stefan Aebi, Karen N. Price, Olivia Pagani, Edda Simoncini, (unknown), R.D. Gelber, Alan S. Coates, Aron Goldhirsch	80
16	Dose-finding study of weekly docetaxel, anthracyclines plus fluoropyrimidines as first-line treatment in advanced breast cancer 2005 ·Annals of Oncology ·Olivia Pagani, Cristiana Sessa, Franco Nolè, Elisabetta Munzone, Diana Crivellari, Davide Lombardi, Beat Thürlimann, Dagmar Hess, Rossella Graffeo, Marco Ruggeri, Sauro Longhi, Aron Goldhirsch	3
17	Phase I clinical and pharmacokinetic study of the oral platinum analogue JM216 given daily for 14 days 1998 ·Annals of Oncology ·Cristiana Sessa, Carla Minoia, A. Ronchi, Massimo Zucchetti, Jean Bauer, Markus Borner, J. de Jong, Olivia Pagani, J. Renard, Carrol S. Weil, M. D’lncalci	45
18	Control of delayed nausea and vomiting with granisetron plus dexamethasone or dexamethasone alone in patients receiving highly emetogenic chemotherapy: A double-blind, placebo-controlled, comparative study 1998 ·Annals of Oncology ·L. Goedhals, Jean‐François Héron, (unknown), Olivia Pagani, Cristiana Sessa	70
19	Phase I clinical and pharmacokinetic study of oral etoposide phosphate. 1995 ·Journal of Clinical Oncology ·Cristiana Sessa, Massimo Zucchetti, T. Cerny, Olivia Pagani, F. Cavalli, (unknown), J. de Jong, (unknown), (unknown), (unknown)	23
20	Chronic oral etoposide in small-cell lung cancer: Clinical and pharmacokinetic results 1993 ·Annals of Oncology ·Cristiana Sessa, Massimo Zucchetti, Valter Torri, Olivia Pagani, Maurizio D’Incalci, (unknown), Giovanni Martinelli, (unknown), Mario Alerci, F. Cavalli	29

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact